BSE filing, NSE: TASTYBITE. Summary written from the filing by ALFA Finder's alert engine.
Tasty Bite Eatables Ltd: key numbers
- Share price
- ₹8,850.00
- Market cap
- ₹2,271 Cr
- Revenue (annual)
- ₹548.7 Cr
- Net profit (annual)
- ₹35.30 Cr
- P/E (TTM)
- 63.2×Sector 38.3×
- Promoter holding
- 74.23%+0.00% QoQ
- FII holding
- 2.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tasty Bite Eatables Ltd
All →Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables declared postal ballot results approving a material related-party transaction with Mars Food UK Limited for purchase of a capital asset. Promoter group did not vote and the resolution passed with 99.99% of votes cast in favour.
Tasty Bite Eatables Board Meeting Date
Tasty Bite Eatables scheduled its Board Meeting for 05 November 2026 to consider un-audited results for the quarter ended 30 September 2026. Trading window remains closed until 48 hours post-announcement.
Tasty Bite Eatables Other Announcement
Tasty Bite Eatables Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance filing.
Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables Limited has issued a Postal Ballot notice seeking shareholder approval for material related party transactions with Mars Food UK Limited.
- Execution
- Financial Year 2026-27
Tasty Bite Eatables Management Change
Tasty Bite Eatables shareholders reappointed director Matthew James Page and reclassified Shashank Shekhar as a director liable to retire by rotation.
Tasty Bite Eatables Annual General Meeting
Tasty Bite Eatables Ltd held its 42nd Annual General Meeting on 13 August 2026. The meeting covered financial statements, dividend declaration, and other business resolutions.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.